Ethyl 2-bromo-6-methylbenzoate
CAS: 1243389-08-3
Rif. 3D-TZB38908
1g | Fuori produzione | ||
5g | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione | ||
500mg | Fuori produzione | ||
2500mg | Fuori produzione |
Informazioni sul prodotto
Ethyl 2-bromo-6-methylbenzoate (EMB) is an analog of the compound ethyl 2-bromo-6-methylbenzoate. It has not been tested in humans, but it has shown potential for use as a discovery agent for cancer treatment. EMB inhibits cellular activity by binding to ft895, which is a protein that plays a role in inflammation and cellular transformation. The pharmacokinetic properties of EMB are not well known because it has not been studied extensively.